ArticleJAAD case reports2018

Talimogene laherparepvec in combination with pembrolizumab leads to a complete response in a patient with refractory Merkel cell carcinoma.

Kristi M Lara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.